Efficacy and safety of linezolid for the treatment of infections in children: a meta-analysis
- 8 April 2014
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 173 (9) , 1179-1186
Abstract
Linezolid is an oxazolidinone antibacterial agent, with activity against Gram-positive bacteria. This study aimed to evaluate the efficacy and safety of linezolid in children with infections caused by Gram-positive pathogens. A systematic search was conducted by two independent reviewers to identify published studies up to September 2013. The accumulated relevant literature was subsequently systematically reviewed, and a meta-analysis was conducted. Eligible studies were randomized controlled trials assessing the clinical efficacy and safety of linezolid in children versus other antimicrobial agents for infections caused by Gram-positive bacteria. The primary outcome was treatment success in patients who received at least one dose of study drug, had clinical evidence of disease, and had complete follow-up. Meta-analysis was conducted with random effects models because of heterogeneity across the trials. Two randomized controlled trials (RCTs), involving 815 patients, were included. Linezolid was slightly more effective than control antibiotic agents, but the difference was not statistically significant [odds ratio (OR) = 1.39, 95 % confidence interval (CI) 0.98–1.98]. Treatment with linezolid was not associated with more adverse effects in general (OR = 0.61, 95 % CI 0.25–1.48). Eradication efficiency did not differ between linezolid and control regimens, but the sample size for these comparisons was small. Conclusion: The use of linezolid cannot be steadily supported from the results of the current meta-analysis. It appears to be slightly more effective than control antibiotic agents, but the difference was not significant, and the serious limitations present in this study restrict its use. Further studies providing evidence for clinical and microbiological efficacy of linezolid will support its use.Keywords
This publication has 29 references indexed in Scilit:
- Clinical experience with linezolid in infants and childrenJournal of Antimicrobial Chemotherapy, 2011
- Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis*Critical Care Medicine, 2010
- Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta‐analysis)Anz Journal of Surgery, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003
- Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in childrenThe Pediatric Infectious Disease Journal, 2003
- Hematologic effects of linezolid in young childrenThe Pediatric Infectious Disease Journal, 2003
- Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant Gram-positive bacterial pathogensThe Pediatric Infectious Disease Journal, 2003
- Linezolid versus vancomycin for treatment of resistant Gram-positive infections in childrenThe Pediatric Infectious Disease Journal, 2003
- External Cooling in the Management of FeverClinical Infectious Diseases, 2000
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?The Lancet, 1998